## Abstract AKR mice, known to develop spontaneous leukemia in almost 100% of cases, were studied throughout their lifespan. Different treatments combining a potent immune stimulator, __Corynebacterium parvum__ (CP), with interferon (IFN) and arginine butyrate were initiated at the 15th week of lif
Antitumor effect of arginine butyrate in conjunction with corynebacterium parvum and interferon
β Scribed by Charles Chany; Italina Cerutti
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- French
- Weight
- 468 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The antitumor effect of arginine butyrate, used alone or in conjunction with interferon (IFN), was studied using randomly selected Swiss mice inoculated i.p. with 10^6^ 180 TG Crocker tumor cells. The results of these different therapeutic regimens were estimated by tumor incidence at 10 days, by the time necessary to protect 50% of the animals, and by the final survival rate. Combined treatment by IFN and arginine butyrate was effective; but in order to compensate for IFN's immune repressive effects, a single injection of Corynebacterium parvum was administered in some experiments prior to IFN and/or arginine butyrate. After this immune potentiation, both IFN and arginine butyrate used separately significantly protected the animals. However, optimal results were obtained when a single C. parvum injection was followed by nine daily alternating shots of arginine butyrate and IFN.
π SIMILAR VOLUMES
It has been observed that patients with metastatic brain lesions developed neurologic symptoms when given Corynebacterium parvum. To obtain more information in patients with intracranial mass lesions, intracranial pressures (ICP) were measured or observed in six patients undergoing C. parvum therapy
## Abstract We have attempted to determine what host mechanisms are responsible for inducing a rapid decrease in the number of Friend leukemia cells (FLC) in the peritoneal cavity of interferonβtreated mice. By injecting radiolabelled FLC, we showed that there was a greater loss of radioactivity fr
## Abstract Lovastatin, the drug used for the treatment of hypercholesterolemia, has previously been reported to exert antitumor activity in experimental murine models. Butyrate and butyric acid derivatives are well known to induce differentiation and apoptosis of tumour cells and also have recentl